Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rimexa MS


May be acceptable
Use with caution

May be acceptable
Rimexa MS :
Type Medicine Pending
Originator Esmeron 50mg
Agent Bellapharma
Distributor Bellapharma
Laboratory MS Pharma
Manufacturer MS Pharma
Manufacturing Type G
Origin Jordan
ATC M03AC09

Your comment will appear shortly after approval

Rimexa MS :

Revision Date : 01/10/2015


Effect Frequency
Airway complication of anaesthesia Very rare
Anaphylactic reactions Very rare
Anaphylactic shock Very rare
Anaphylactoid reactions Very rare
Anaphylactoid shock Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Bronchospasm Very rare
Circulatory collapse Very rare
Delayed recovery from anaesthesia Uncommon
Drug ineffective Uncommon
Face oedema Very rare
Flushing Very rare
Hypersensitivity Very rare
Hypotension Uncommon
Injection site pain Uncommon
Injection site reaction Uncommon
Malignant hyperthermia Very rare
Muscle weakness Very rare
Neuromuscular block prolonged Uncommon
Paralysis flaccid Very rare
Rash erythematous Very rare
Shock Very rare
Skin rash Very rare
Steroid myopathy Very rare
Tachycardia Uncommon
Therapeutic response decreased Uncommon
Therapeutic response increased Uncommon
Urticaria Very rare

Different Units By MoH Code

Rimexa MS  MoH 2061128 :
Form Solution for injection
Packaging Bottle
Package Size 10x5ml
Strength 50mg
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 29/09/2017
Pending Year 10/06/2019
Pending Reason Incomplete file
Rejection Year 25/06/2021
Rejection Reason Falsified file


Price Comparison

● Country: Jordan
● Package Size: 10
● Public Price: 38.63 JOD ( 4,837,287.23 LBP )
● Pack size unit used: 10
● Cost/Unit: 3,863 JOD ( 375,663.00 LBP )
● Reference: JFDA
● Pricing Date: 25/05/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info